DEFINITION AND EPIDEMIOLOGY
Chronic obstructive pulmonary disease (COPD) is a disease state characterized by chronic airflow obstruction; thus, pulmonary function testing is central to its diagnosis. The presence of airflow obstruction is determined by a reduced ratio of the forced expiratory volume in 1 s (FEV1) to the forced vital capacity (FVC). Among individuals with a reduced FEV1/FVC ratio, the severity of airflow obstruction is determined by the level of reduction in FEV1 (Table 140-1): ≥80% is stage I, 50–80% is stage II, 30–50% is stage III, and <30% is stage IV. Cigarette smoking is the major environmental risk factor for COPD. The risk of COPD increases with cigarette smoking intensity, which is typically quantified as pack-years. (One pack of cigarettes smoked per day for 1 year equals 1 pack-year.) Individuals with airway hyperresponsiveness and certain occupational exposures (e.g., coal mining, gold mining, and cotton textiles) are likely also at increased risk for COPD. In countries in which biomass combustion with poor ventilation is used for cooking, an increased risk of COPD among women has been reported. COPD is a progressive disorder; however, the rate of loss of lung function often slows markedly if smoking cessation occurs. In normal individuals, FEV1 reaches a lifetime peak at around age 25 years, enters a plateau phase, and subsequently declines gradually and progressively. Subjects can develop COPD by having reduced maximally attained lung function, shortened plateau phase, or accelerated decline in lung function.
TABLE 140-1GOLD CRITERIA FOR COPD SEVERITY |Favorite Table|Download (.pdf) TABLE 140-1GOLD CRITERIA FOR COPD SEVERITY
|GOLD Stage ||Severity ||Symptoms ||Spirometry |
|0 ||At risk ||Chronic cough, sputum production ||Normal |
|I ||Mild ||With or without chronic cough or sputum production ||FEV1/FVC <0.7 and FEV1 ≥80% predicted |
|IIA ||Moderate ||With or without chronic cough or sputum production ||FEV1/FVC <0.7 and FEV1 ≥50% but <80% predicted |
|III ||Severe ||With or without chronic cough or sputum production ||FEV1/FVC <0.7 and FEV1 ≥30% but <50% predicted |
|IV ||Very severe ||With or without chronic cough or sputum production || |
FEV1/FVC <0.7 and FEV1 <30% predicted
FEV1 <50% predicted with respiratory failure or signs of right heart failure
Symptoms often occur only when COPD is advanced; thus, early detection requires spirometric testing. The Pao2 typically remains near normal until the FEV1 falls to <50% of the predicted value. Hypercarbia and pulmonary hypertension are most common after FEV1 has fallen to <25% of predicted. COPD pts with similar FEV1 values can vary markedly in their respiratory symptoms and functional impairment. COPD often includes periods of increased respiratory symptoms, such as dyspnea, cough, and phlegm production, which are known as exacerbations. Exacerbations are often triggered by bacterial and/or viral respiratory infections. These exacerbations become more common as COPD severity increases, but some individuals are much more susceptible to developing exacerbations than others with similar degrees of airflow obstruction.
Subjects with COPD usually have smoked ≥20 pack-years of cigarettes. Common symptoms include cough and phlegm production; individuals with chronic productive cough for 3 months per year for the preceding 2 years have chronic bronchitis. However, chronic bronchitis without airflow obstruction is not included within COPD. Exertional dyspnea is a common and potentially disabling symptom in COPD pts. Exercise involving upper-body activity is especially difficult for severe COPD pts. Weight loss and cachexia are common in advanced disease. Hypoxemia and hypercarbia may result in fluid retention, morning headaches, sleep disruption, erythrocytosis, and cyanosis.
Exacerbations are more frequent as disease progresses and are most often triggered by respiratory ...